Photo taken from Agenus/LinkedIn
Apr 9, 2024, 15:56
We’ve been energized and inspired by our time at AACR2024 – Agenus
Agenus shared a post on LinkedIn:
“We’ve been energized and inspired by our time at AACR2024.
Yesterday our Vice President of Research, Dhan Chand, presented preclinical data on the activity of BMS-986442, Bristol Myers Squibb’s bispecific TIGIT program that was licensed from Agenus in 2021 (formerly AGEN1777). View the presentation.”
Source: Agenus/LinkedIn